SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-427766
Filing Date
2013-11-05
Accepted
2013-11-05 16:31:00
Documents
4
Period of Report
2013-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d623103d8ka.htm 8-K/A 36346
2 EX-3.1 d623103dex31.htm EX-3.1 37652
3 GRAPHIC g623103img01.jpg GRAPHIC 13148
4 GRAPHIC g623103img02.jpg GRAPHIC 8018
  Complete submission text file 0001193125-13-427766.txt   104754
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36172 | Film No.: 131193008
SIC: 2836 Biological Products, (No Diagnostic Substances)